Here are the Investor speakers from our Sold-Out Boston VC Showcase, sponsored by Hale and Dorr, Grant Thornton. This event was in Boston on Wed, May 26, 2004.
No Speakers - Just Exhibiting VCs- Click here for Fund descriptions
Keiretsu Forum (Angel Investor Network)
Keiretsu Forum is an investment community of accredited private equity investors, VCs and corporate/institutional investors. Keiretsu Forum members invest in diverse early stage opportunities in the range of $250K to $1.5 Million.
Focuses on early-stage Communications Infrastructure and Software and Services companies. Our team of experienced venture capital partners works closely with entrepreneurial management teams to help them build outstanding growth companies and deliver superior returns to investors. With over $350 million of committed capital under management, the firmís partners have invested in more than 130 high-growth companies that are leaders in their industry categories. Focus: Communications Infrastructure and Software and Services. We are early stage investors, generally investing as a lead or co-lead investor in the first or second round of a companyís financing history. Often, we are the first institutional capital invested in an early-stage company.
Ticonderoga's primary investment focus is on later stage, private equity investments in enterprise software and business services firms. Ticonderoga's strategy aligns to the rebuilding of the technology-based operating capabilities of the business community. We believe the second generation of Web-enabled business solutions that combine both proprietary technology and human-based services bring the best of both the IT services and software worlds. Our capital is typically used to accelerate revenue growth, make acquisitions, or provide liquidity to founders and existing shareholders.
DFJ New England Fund
Early-stage venture capital firm, providing expert counsel and financing to emerging companies that display the promise of significant growth and value creation. DFJ New England is a ground-floor investor. Typically, we participate in the seed or A round, taking a significant stake in the company and becoming an active member of the Board of Directors. Focus: Software infrastucture, enterprise software, and software-based services. Networking businesses Infrastructural technologies for computing and telecommunications.
Adams, Harkness Ventures
We invest in early- to mid-stage companies. Companies at this stage have largely completed initial product development efforts and are initiating or expanding product commercialization. As such, some level of customer adoption has been achieved. Focus Areas: Software, Technology Manufacturing Solutions, Emerging Growth Semiconductors, Technology Services, Resource Optimization Technologies, Interactive Entertainment.
The View Group
The View Group is an international private equity firm. We invest in high potential companies, providing them with capital, strategic guidance and access to global operations and markets. With offices and professionals in the US and India, View is dedicated to playing an integral role in the growth of world-class businesses by enabling them to access efficient operations in India and markets worldwide, enhancing their competitiveness and transforming their industries.
Longworth Venture Partners
Has a single focus - partnering with exceptional entrepreneurs to build leading technology companies. Focus: early and expansion-stage venture capital firm staffed by successful, experienced high-tech entrepreneurs and investors. Industry Sectors Enterprise Application Software, Infrastructure Software, IT-enabled Business Services. Stage: Early and expansion-stage. Generally a company's first or second round of financing. We participate in financings ranging from $500,000 - $15,000,000.
Mi3 Venture Partners is an early-stage life science technologies-focused
venture fund headquartered in Boston, MA. To be considered for an
investment by Mi3, a company must address a critical unmet clinical need
with a breakthrough technology that can be developed, commercialized, and
exited with a moderate amount of private capital. Mi3 focuses on those
companies that convert novel biology into products through engineering or
the application of the physical sciences and avoids de novo biology
investments such as biotech or pharmaceuticals.
HarbourVest Partners has a conscious strategy of seeking out investment opportunities in three distinct areas: new partnerships, secondary interests in partnerships, and direct investments in operating companies. Fund-of-Funds: HarbourVest is an investor in new partnerships. Approximately 65% of our assets under management are invested in such partnerships. We select experienced fund managers who have the potential to generate superior rates of return. Direct Investments: A direct investor in operating companies in select industries. Focus: software, internet infrastructure, telecommunications, networking, and management buyouts of operating companies.
Waltham, MA based venture capital firm managing approximately $150 million of capital focused on the information technology market. Ironside Ventures is one of the leaders in a new generation of venture capital investors that has emerged from the difficult market conditions of the past several years. Invests in information technology companies with the potential to be market leaders. We are stage agnostic, investing between $1 million to $10 million in companies at all stages of the growth cycle. We are comfortable being the first institutional investor, and building value-added investor syndicates. We also invest in later stage companies looking for expansion capital as well as our specific expertise.
Formed by the Egan family with the objective of helping future entrepreneurs build significant enterprises. We seek for opportunities to invest in companies where we can provide more than just capital. $100 million of capital is prepared to make investments in the range of $1 million to $6 million, but our preferred initial appetite is between $2 and $3 million. Since providing assistance to our portfolio companies is such an important part of our investment philosophy, we nearly always require a board seat. We find that by being an active member of the Board of Directors we are in a position to share our insights and participate in the strategic direction of the Company.
Horizon Technology Finance
A Premier Venture Debt Finance Company Serving the High Technology and Life Science Markets. At Horizon, we make venture loans to emerging technology companies in the Life Science, Health Care, Information Technology and Software industries. The Founders and Directors of Horizon collectively have over 50 years of venture lending experience.